Literature DB >> 22614904

Natural history of conduction abnormalities in a patient with Kearns-Sayre syndrome.

Hitesh Agrawal1, Omonigho Ekhomu, Hyoung Won Choi, Zahra Naheed.   

Abstract

Kearns-Sayre syndrome is a rare mitochondrial disorder characterized by large-scale deletion or rearrangement of mitochondrial DNA, which is usually not inherited but occur spontaneously probably at the germ cell level or very early in embryonic development by Mehndiratta et al. (Neurol India 50:162-167, 2002). Neuromuscular and cardiac conduction abnormalities are most commonly involved in these patients, which may have subtle presenting signs.

Entities:  

Mesh:

Year:  2012        PMID: 22614904     DOI: 10.1007/s00246-012-0365-x

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  8 in total

1.  ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines).

Authors:  Gabriel Gregoratos; Jonathan Abrams; Andrew E Epstein; Roger A Freedman; David L Hayes; Mark A Hlatky; Richard E Kerber; Gerald V Naccarelli; Mark H Schoenfeld; Michael J Silka; Stephen L Winters; Raymond J Gibbons; Elliott M Antman; Joseph S Alpert; Gabriel Gregoratos; Loren F Hiratzka; David P Faxon; Alice K Jacobs; Valentin Fuster; Sidney C Smith
Journal:  Circulation       Date:  2002-10-15       Impact factor: 29.690

2.  [Kearns-Sayre syndrome. A rare indication for prophylactic cardiac pacing].

Authors:  P Lewy; G Leroy; R Haiat; C Halphen; L Kerrad; M Sander; M Weingrod
Journal:  Arch Mal Coeur Vaiss       Date:  1997-01

3.  Neurological mitochondrial cytopathies.

Authors:  M M Mehndiratta; P Agarwal; M Tatke; M Krishnamurthy
Journal:  Neurol India       Date:  2002-06       Impact factor: 2.117

4.  [Cardiac involvement in Kearns-Sayre syndrome].

Authors:  Carlos F Barrera-Ramírez; Héctor M Barragán-Campos; Hermes Ilarraza; Pedro Iturralde; María C Avila-Casado; Jorge Oseguera
Journal:  Rev Esp Cardiol       Date:  2005-04       Impact factor: 4.753

5.  Lumping or splitting? "Ophthalmoplegia-plus" or Kearns-Sayre syndrome?

Authors:  R A Berenberg; J M Pellock; S DiMauro; D L Schotland; E Bonilla; A Eastwood; A Hays; C T Vicale; M Behrens; A Chutorian; L P Rowland
Journal:  Ann Neurol       Date:  1977-01       Impact factor: 10.422

Review 6.  Kearns-Sayre syndrome: a case report and review of cardiovascular complications.

Authors:  Timothy J Young; Amit K Shah; Mun Heng Lee; David L Hayes
Journal:  Pacing Clin Electrophysiol       Date:  2005-05       Impact factor: 1.976

7.  Indications for pacemaker implantation in the Kearns-Sayre syndrome.

Authors:  P E Polak; F Zijlstra; J R Roelandt
Journal:  Eur Heart J       Date:  1989-03       Impact factor: 29.983

8.  Clinical syndromes associated with ragged red fibers.

Authors:  L P Rowland; D M Blake; M Hirano; S Di Mauro; E A Schon; A P Hays; D C Devivo
Journal:  Rev Neurol (Paris)       Date:  1991       Impact factor: 2.607

  8 in total
  3 in total

1.  Kearns-Sayre Syndrome Minus: Two Cases of Identical Large-Scale Mitochondrial DNA Deletions with Presentations outside the Classical Triad.

Authors:  Shir Wey Gloria Pang; Hencher Han Chih Lee; Carol Ng Wing Kei; Eric Kin Cheong Yau; Joannie Hui
Journal:  Case Rep Genet       Date:  2022-04-23

2.  A novel mitochondrial DNA deletion in a patient with Kearns-Sayre syndrome: a late-onset of the fatal cardiac conduction deficit and cardiomyopathy accompanying long-term rGH treatment.

Authors:  Monika Obara-Moszynska; Jaroslaw Maceluch; Waldemar Bobkowski; Artur Baszko; Oskar Jaremba; Maciej R Krawczynski; Marek Niedziela
Journal:  BMC Pediatr       Date:  2013-02-20       Impact factor: 2.125

3.  Clinical and Brain Magnetic Resonance Imaging Features in a Cohort of Chinese Patients with Kearns-Sayre Syndrome.

Authors:  Meng Yu; Zhe Zhang; Qing-Qing Wang; Jing Liu; Yue-Huan Zuo; Lei Yu; Jiang-Xi Xiao; Wei Zhang; Yun Yuan; Zhao-Xia Wang
Journal:  Chin Med J (Engl)       Date:  2016-06-20       Impact factor: 2.628

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.